Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jul 23, 2021
- Accession no.
- 0001447362-21-000178
- Filed
- Jul 23, 2021
- Trade date
- Jul 21, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions. Open-market sales total $850.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2021 | Common Stock | SSaleDisposed | −2,125 | $66.53F2 | −$141,376.25 | 413,893 | Direct | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −1,900 | $67.79F3 | −$128,801 | 411,993 | Direct | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −5,975 | $68.68F4 | −$410,363 | 406,018 | Direct | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −167 | $66.38F6 | −$11,085.46 | 154,626 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −166 | $67.75F8 | −$11,246.5 | 154,460 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −500 | $68.68F9 | −$34,340 | 153,960 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −167 | $66.38F6 | −$11,085.46 | 177,467 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −167 | $67.75F8 | −$11,314.25 | 177,300 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −500 | $68.68F9 | −$34,340 | 176,800 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −166 | $66.38F6 | −$11,019.08 | 164,867 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −167 | $67.75F8 | −$11,314.25 | 164,700 | Indirect | |
| Jul 21, 2021 | Common Stock | SSaleDisposed | −500 | $68.68F9 | −$34,340 | 164,200 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $66.080 to $67.000, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $67.390 to $68.320, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $68.405 to $69.020, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $66.080 to $66.700, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $67.300 to $67.970, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $68.450 to $68.980, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.